CD34 and acute myeloid leukemia: Moreover, a recent investigation by Folkerts et al. revealed that various leukemic cell lines, and purified CD34+ cells from AML patients, exhibit inconsistent levels of basal autophagic flux, with particularly high levels in immature ROSlow LSC blasts and adverse AML risk groups, such as those with TP53 mutations [117].